Albus is pleased to announce it has joined the AstraZeneca BioVentureHub!

The BioVentureHub offers emerging life science companies and academic teams an innovative way to access AstraZeneca’s experience, expertise and infrastructure.
Embedded at the heart of AstraZeneca Gothenburg, BioVentureHub members become part of a unique, open and collaborative scientific community, with the same access to the facilities as AstraZeneca staff.

Our CEO Mikesh Udani and BioVentureHub CEO Magnus Björsne talk about Albus joining the BioVentureHub in the video linked below.